Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo J.

J Clin Oncol. 2018 May 10;36(14):1419-1427. doi: 10.1200/JCO.2017.75.8219. Epub 2018 Feb 12.

2.

Herpesviruses as therapeutic agents.

Tufaro F, Markert JM.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 76.

3.

Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized mice.

Burrows M, Assundani D, Celis E, Tufaro F, Tanaka A, Bradley WG.

BMC Complement Altern Med. 2009 Nov 30;9:49. doi: 10.1186/1472-6882-9-49.

4.

Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity.

Uyama T, Ishida M, Izumikawa T, Trybala E, Tufaro F, Bergström T, Sugahara K, Kitagawa H.

J Biol Chem. 2006 Dec 15;281(50):38668-74. Epub 2006 Oct 13.

5.

Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells.

Mårdberg K, Trybala E, Tufaro F, Bergström T.

J Gen Virol. 2002 Feb;83(Pt 2):291-300.

PMID:
11807221
6.

The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Duncan G, McCormick C, Tufaro F.

J Clin Invest. 2001 Aug;108(4):511-6. Review. No abstract available.

7.

Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.

Cheung PK, McCormick C, Crawford BE, Esko JD, Tufaro F, Duncan G.

Am J Hum Genet. 2001 Jul;69(1):55-66. Epub 2001 Jun 5.

8.

Replicating herpes simplex virus vectors for cancer gene therapy.

Yeung SN, Tufaro F.

Expert Opin Pharmacother. 2000 May;1(4):623-31. Review.

PMID:
11249507
9.

Herpes simplex virus: discovering the link between heparan sulphate and hereditary bone tumours.

McCormick C, Duncan G, Tufaro F.

Rev Med Virol. 2000 Nov-Dec;10(6):373-84. Review.

PMID:
11114076
10.
11.

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F, Martuza RL.

Gene Ther. 2000 May;7(10):867-74.

12.

Evidence of selective processing of immunodominant epitopes in virally infected cells.

Zhang QJ, Chen SS, Saari CA, Massuci MG, Tufaro F, Jefferies WA.

J Immunol. 2000 May 1;164(9):4513-21.

13.
14.

New perspectives on the molecular basis of hereditary bone tumours.

McCormick C, Duncan G, Tufaro F.

Mol Med Today. 1999 Nov;5(11):481-6. Review.

PMID:
10529789
15.

Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes.

Horsburgh BC, Hubinette MM, Qiang D, MacDonald ML, Tufaro F.

Gene Ther. 1999 May;6(5):922-30.

16.
17.

Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes.

Horsburgh BC, Hubinette MM, Tufaro F.

Methods Enzymol. 1999;306:337-52. No abstract available.

PMID:
10432464
18.

A perspective of gene therapy in the glaucomas.

Kaufman PL, Jia WW, Tan J, Chen Z, Gabelt BT, Booth V, Tufaro F, Cynader M.

Surv Ophthalmol. 1999 Jun;43 Suppl 1:S91-7.

PMID:
10416752
19.

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.

Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K.

J Biol Chem. 1998 Oct 9;273(41):26265-8.

20.

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.

McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP, Tufaro F.

Nat Genet. 1998 Jun;19(2):158-61.

PMID:
9620772
21.

The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans.

Jacquet A, Haumont M, Chellun D, Massaer M, Tufaro F, Bollen A, Jacobs P.

Virus Res. 1998 Feb;53(2):197-207.

PMID:
9620211
22.
23.

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, McCutcheon K, Singaraja R, Kazemi-Esfarjani P, Devon R, Kim SU, Bredesen DE, Tufaro F, Hayden MR.

Nat Genet. 1998 Feb;18(2):150-4.

PMID:
9462744
24.

Neutralization of cytomegalovirus virions: the role of complement.

Spiller OB, Hanna SM, Devine DV, Tufaro F.

J Infect Dis. 1997 Aug;176(2):339-47.

PMID:
9237698
25.

Virus entry: two receptors are better than one.

Tufaro F.

Trends Microbiol. 1997 Jul;5(7):257-8; discussion 258-9. No abstract available.

PMID:
9234500
26.

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

Sasadeusz JJ, Tufaro F, Safrin S, Schubert K, Hubinette MM, Cheung PK, Sacks SL.

J Virol. 1997 May;71(5):3872-8.

27.
28.

A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult.

Jia WW, Wang Y, Qiang D, Tufaro F, Remington R, Cynader M.

Brain Res Mol Brain Res. 1996 Dec;42(2):350-3.

PMID:
9013793
29.

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells.

Spiller OB, Morgan BP, Tufaro F, Devine DV.

Eur J Immunol. 1996 Jul;26(7):1532-8.

PMID:
8766557
30.

Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH, Eisenberg RJ.

J Virol. 1995 Jul;69(7):4471-83.

31.

Cell surface proteoglycans are not essential for infection by pseudorabies virus.

Karger A, Saalmüller A, Tufaro F, Banfield BW, Mettenleiter TC.

J Virol. 1995 Jun;69(6):3482-9.

33.

Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection.

Banfield BW, Leduc Y, Esford L, Visalli RJ, Brandt CR, Tufaro F.

Virology. 1995 Apr 20;208(2):531-9.

34.
35.

Examination of conditions affecting the efficiency of HVS-1 amplicon packaging.

Wu X, Leduc Y, Cynader M, Tufaro F.

J Virol Methods. 1995 Mar;52(1-2):219-29.

PMID:
7769035
36.

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

Jia WW, McDermott M, Goldie J, Cynader M, Tan J, Tufaro F.

J Natl Cancer Inst. 1994 Aug 17;86(16):1209-15.

PMID:
8040888
37.

A recombinant herpes simplex type 1 virus expressing antisense 5-HT2 receptors.

Jia WW, Gatzke L, Wu X, Wang Y, Tufaro F, Cynader M.

Gene Ther. 1994;1 Suppl 1:S75. No abstract available.

PMID:
8542421
39.
40.
41.

Toxin resistance and reduced secretion in a mouse L-cell mutant defective in herpes virus propagation.

Michaelis C, Banfield BW, Gruenheid S, Tsang Y, Lippe R, Jefferies WA, Wattenberg BW, Tufaro F.

Biochem Cell Biol. 1992 Oct-Nov;70(10-11):1209-17.

PMID:
1338412
42.
43.

Characterization of a novel liver-specific enhancer in the human prothrombin gene.

Chow BK, Ting V, Tufaro F, MacGillivray RT.

J Biol Chem. 1991 Oct 5;266(28):18927-33.

44.
46.

Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood.

Neyndorff HC, Bartel DL, Tufaro F, Levy JG.

Transfusion. 1990 Jul-Aug;30(6):485-90.

PMID:
2165643
47.

Serological distance coefficients.

Hoffmann GW, Tufaro F.

Immunol Lett. 1989 Aug;22(2):83-90.

PMID:
2777337
48.
49.

Post-transcriptional restriction of gene expression in sea urchin interspecies hybrid embryos.

Conlon RA, Tufaro F, Brandhorst BP.

Genes Dev. 1987 Jun;1(4):337-46.

50.

Structural and functional analysis of an alternatively spliced chicken TK messenger RNA.

Merrill GF, Tufaro FD.

Nucleic Acids Res. 1986 Aug 11;14(15):6281-97.

Supplemental Content

Loading ...
Support Center